Navigation Links
Model N Extends its Industry-Leading Contract Management Offerings with Contract Authoring Capabilities

New Solution Improves Offer-to-Contract Effectiveness for Sales, Legal, and Finance Organizations

Redwood Shores, California (PRWEB) February 24, 2010 -- Model N, Inc., the leader in Revenue Management solutions, today announced at RAINMAKER 2010 its new Contract Authoring solution, which extends the Model N Revenue Management Suite by allowing business users to rapidly develop contract documents and templates, negotiate and redline contracts, and manage workflows and approvals in the offer development process. Model N Contract Authoring integrates directly into the full life cycle processes of the Model N Revenue Management Suite, enabling Life Science and High Tech organizations to cut contract cycle times, boost productivity, and enhance contract compliance. Model N Contract Authoring is available immediately for current Model N customers, and is also available as an optional extension to Model N's Contract Management application for new Model N customers.

"We are continually looking for ways to enhance Revenue Management life cycle process efficiency and to enable our customers to more quickly and effectively respond to market opportunities," said Ariel Zach, Vice President of Product Development for Model N. "After delivering major process improvements and enhancing flexibility in managing pricing and incentive programs within contracts, we turned our attention to improving how our customers develop contract documents and collaborate among their sales, finance, and legal teams, as well as their customers, to deliver efficiencies in the offer-to-contract process. Contract Authoring is a natural extension of the Revenue Management Suite."

Model N Contract Authoring incorporates Selectica, Inc.'s (Nasdaq: SLTC) best-of-breed Contract Lifecycle Management (CLM) into Model N's industry-leading Revenue Management Suite. Model N chose Selectica's solution after an extensive evaluation process to incorporate the most robust, comprehensive, scalable, and flexible contract authoring technology as a foundation for the Model N Contract Authoring application.

Model N Contract Authoring is a highly collaborative solution for creating and managing agreements, offering enhanced capabilities for building customer and deal-specific pricing strategies. Key contract data and terms are automatically synchronized with downstream Model N applications, ensuring seamless integration of transactional, legal, and financial information in the revenue life cycle, from contract management and compliance to rebate management and regulatory reporting. This seamless approach is the hallmark of Model N's integrated Revenue Management platform and ensures that customers accurately capture contract terms and consistently track milestones and compliance measurements, while streamlining all aspects of the contract lifecycle, including offer development and approvals as well as contract execution, amendment, and renewal management.

Collaborative Features Ensure Speedy Execution while Maintaining Control and Visibility

Model N Contract Authoring allows customers to leverage advanced contract authoring capabilities that greatly enhance offer development efforts and promote vital cross-functional collaboration in the contract life cycle. Key features include:

  • Seamless MS Word integration; drag-and-drop contract template creation using a library of approved language and terms
  • Dynamic clause library support for managing legal and contractual terms and conditions
  • Highly-configurable dynamic workflows with serial and parallel approvals; graphical views of contract approval status
  • Third-party contract support with ability to import documents in MS Word, PDF, or via fax and extract and map critical terms and clauses
  • Customizable notifications based on key events as well as external system updates
  • Flexible and sophisticated reports and dashboards with full audit trail down to the field level

Supporting Quotes

"These new contract authoring capabilities will allow Life Science sales, finance, IT and legal teams to rapidly transform innovative and complex business strategies into reality," said Sujay Jadhav, Life Sciences General Manager at Model N. "This is yet another example of our commitment to empowering our customers with maximum business agility."

"Our semiconductor, component, and high tech manufacturing customers are very interested in pursuing innovative pricing and contracting strategies that improve margins and market share without incurring unwanted compliance issues," said Rich Fitchen, High Tech General Manager at Model N. "By integrating world-class contract authoring into our High Tech Revenue Management Suite, Model N is delivering the only comprehensive solution in the market that supports growth while mitigating compliance risk."

Supporting Resources

Model N Contract Authoring Data Sheet

Model N Life Science Revenue Management Suite

Model N High Tech Revenue Management Suite

AMR Research Report: Using Revenue and Contract Management as a Strategic Weapon

About Model N

Model N is the leader in Revenue Management solutions, offering an integrated suite of applications for analytics, pricing strategy and execution, contracts, compliance, rebates, fees and chargebacks optimized for the industry practices of Life Sciences and High Tech companies. Enabling the creation of a seamless, end-to-end process from price setting through settlements payment, Model N's uniquely integrated approach eliminates revenue leakage and delivers the visibility and controls needed to avoid the risks of non-compliance to government reporting regulations such as Sarbanes-Oxley and government pricing requirements. Customers include: Boston Scientific Corporation; Bristol-Myers Squibb Company; Cypress Semiconductor Corporation; Intersil Corporation; Linear Technology Corporation; Medtronic, Inc.; Microchip Technology Inc.; Micron Technology Inc.; Ortho-Clinical Diagnostics, a Johnson & Johnson company; ON Semiconductor, Inc. and Pfizer, Inc.; and STMicroelectronics. Model N is located in Redwood Shores, California. For additional information, visit

Model N is a mark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

2. Biomodels Scientists Report Development of a Novel Model for Cancer Treatment-Related Fatigue
3. Lubris, Biomodels Report on Potential New Therapy for Osteoarthritis
4. Scientists use math modeling to predict unknown biological mechanism of regulation
5. DIA/FDA/PhRMA Conference To Expand The Role Of Modeling And Simulation In Clinical Drug Development
6. Life Science Organizations Participate in Economic Recovery by Purchasing Late-Model Lab Equipment
7. New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology
8. Cellworks Group and ISP Personal Care Collaborate to Demonstrate Effectiveness of Proteomics-Based Computer Modeling of Skin Biology
9. Transposagen Creates a Rat Model of the Human Immune System
10. Model predicts evolution of Mediterranean landscape following fires
11. "Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila
Post Your Comments:
(Date:11/30/2015)... 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") ... Wong to its Board of Directors to replace Dr. ... a wealth of experience as co-founder of Resverlogix, with expertise ... --> --> Dr. Wong remarked, "I ... directors. Zenith,s long standing expertise in epigenetics and the advanced ...
(Date:11/30/2015)... -- TapImmune, Inc. (TPIV), a clinical-stage ... and gene-based immunotherapeutics and vaccines for the treatment of ... presenting at the 8 th Annual LD Micro ... PT. Dr. John N. Bonfiglio a TapImmune ... presentation and will join TapImmune management in meeting with ...
(Date:11/30/2015)... 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW ... therapies for solid tumor cancers, announced today that the ... and the Company welcomes Neil Woodford,s call ... anonymous internet report on NW Bio.  The Company,s Board ... Powers stated, "We agree with Mr. Woodford that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to announce ... offered in symposia, oral sessions, workshops, awards, and posters. The core of ... applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food ...
Breaking Biology Technology:
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
Breaking Biology News(10 mins):